John Henderson
Long/short equity, growth, momentum, event-driven

MiMedx Group Inc. - The Next Disruptive Force In Regenerative Medicine

MiMedx Group Inc. (NASDAQ:MDXG) is a regenerative biomaterials company with a patented allograft tissue technology that has application potential in a wide array of healthcare fields. Led by CEO Parker Petit, a legend in the healthcare space who previously sold two companies for billions, and a number of high-level executives from his previous ventures, MiMedx has assembled a management team with the experience and savvy to create another billion dollar market-cap company.

With a $10 billion opportunity in front of it, which could potentially grow into a $15-20 billion opportunity, MiMedx is on a runway which could create exponential growth over the next few years. Although shares of MDXG have already enjoyed nice gains since the...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details